Antibacterials Flashcards

1
Q

Anti-microbial

A

Inhibits growths of micro-organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anti-bacterial

A

Inhibits growth of bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antibiotic

A
  • Inhibits growth of micro-organisms
  • Made by other micro-organisms
  • Extended to include synthetic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOA of Anti-bacterials

A
  1. Cell wall synthesis inhibitors
  2. Protein synthesis inhibitors
  3. Drugs that affect nucleic acid synthesis
  4. Urinary antiseptics
  5. Miscellaneous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bacteriostatic vs Bactericidal

A

Bacteriostatic = Reversible inhibition of growth
Bactericidal = Irreversible inhibition of growth
- Immunocompromised pts
- Life-threatening situations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Selective toxicity

A

Ability to injure/kill an invading microorganism w/o harming host cell
- Inc selective toxicity = Dec AE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Post-antibiotic effect

A

When the killing action continues once drug plasma levels are below measurable levels

  • lag time required for synthesis of new enzymes or cellular components
  • persistence of agent at target site
  • enhanced susceptibility of bacteria to phagocytic/ defense mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antibacterial spectrum

A

Broad spectrum - against several group of micro-organism
Narrow spectrum- against few groups of micro-organisms
Extended spectrum - against gram +ve + some gram -ve micro-organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Broad spectrum Antibiotic uses

A
  • Empiric therapy

- Mixed infection (multiple bacteria present)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Disadvantages of Broad Spectrum Antibiotics

A
  • Selection of multi-drug resistant

- Disruption of normal flora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Uses of Narrow Spectrum Antibiotics

A
  • Treating infections of known origin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Disadvantages of Narrow- Spectrum Antibiotics

A
  • Must know causative organism

- Not useful for empiric therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Uses of Extended Spectrum

A
  • Empiric therapy

- Mixed infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Disadvantages of Extended Spectrum drugs

A
  • Selection of multi-drug resistant bacteria

- Disruption of normal flora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Minimum effective dose/ Minimun inhibitory Conc

A

Lowest conc. of antibiotic that prevents visible growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Minimal Bactericidal Concentration (MBC)

A

Lowest concentration of antibiotic that results in a 99.9% decline in colony count after overnight broth dilation incubation.

MBC (truly bactericidal agent) =/just slightly > MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Factors for selecting the right agent

A
  1. Organism identity
  2. Organism susceptibility to agent
  3. Necessity of empiric therapy
  4. Site of infection
  5. Pharmacological factors
  6. Patient factors
  7. Cost of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Actions in Gram +ve & Gram -ve organisms based on Cell wall

A

Gram +ve- Will NOT block some substances so they will easy pass through
- Thick mesh-like cell wall made of peptidoglycan

Gram -ve - Will block passage of some substances to cell membrane due to the Lipopolysaccharide layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Development of Antibiotic resistance

A

Antibiotic kill sensitive bacteria but not the rare resistant bacteria– > Resistant bacteria multiplies & passes on the resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanisms of Resistance

A
  1. Altered uptake of Antibiotic
    - Dec permeability or uptake mechanisms. Inc in multi-drug resistance pumps
  2. Altered target
    - change in receptor site affinity or modification of targeted metabolic pathways
  3. Drug inactivation
    - Bacteria produce enzymes that inactivate drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Types of Resistance

A
  1. ## Primary
  2. ## Acquired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Empiric therapy

A
Given when immediate therapy is requires
 CHoice of drug is influenced by:
- Site of infection
- Pt. Hx
Broad spectrum may be required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Site of Infection

A

Penetration of BBB

  1. Lipid solubility
  2. Molecular weight - Larger = Less likely to penetrate
  3. Protein binding of the drug = Inc binding = Dec free drug conc available for penetration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pharmacological factors

A
  1. Route of administration
  2. Route of elimination
  3. Half life affected by diseases & other drugs
  4. Drug interaction
  5. Dosing schedule
  6. AEs & Idiosyncratic responces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Route of Administration

A

Mild infection = Oral
Serious infection - Parenteral

  • Drugs w/ poor absorption from GI tract = Parenteral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Complications of Antibiotic therapy

A
  1. Hypersensitivity (Urticaria –> Anaphylactic shock)
  2. Direct toxicity (affect hosts cellular processes)
  3. Superinfection (new or secondary infection that occurs during antimicrobial use )

BENEFITS > RISKS

27
Q

Patient factors

A
  1. Immune state
  2. Renal or Hepatic dysfunction
  3. Poor perfusion
  4. Age
  5. Pregnancy
  6. Lactation
28
Q

Advantages of Combination Therapy

A
  • Achieve synergistic effects
  • Emergency situation
  • Delay resistance
  • Treat mixed infection
  • Treat immunosuppressed
29
Q

Mechanism of Synergism

A
  1. Sequential blockade
  2. Blockade of drug-inactivating enzymes
  3. Enhanced drug uptake
30
Q

Disadvantages of Combination Therapy

A
  • Can select for multi-drug resistant bacteria
  • Some agents only act on multiplying bacteria & if combined w/ another agent that causes bacteriostasis they will be less effective
31
Q

Antimicrobial Chemoprophylaxis

A
  • Should always be directed toward a specific pathogen
  • No resistance should develop
  • Should be used for a limited duration
  • Conventional therapeutic doses should be employed
  • Should only be used in situations of documented drug efficacy
32
Q

Inhibitors of Cell Wall Synthesis (classes & names)

A
  1. B-lactam Antibiotics
    - Penicillin
    - Cephalosporins
    - Carbapenems
    - Monobactams
  2. Vancomycin
  3. Daptomycin
  4. Bacitracin
33
Q

Features of Cell wall Synthesis Inhibitors

A
  • Selective toxicity- Mammalian cell do NOT have cell wall
  • Inactive against organisms w/o Peptidoglycan cell wall (mycoplasma, protozoa, fungi, viruses)
  • Require actively proliferating bacteria
34
Q

Peptidoglycan

A

Chains of Polysaccharides & polypeptides that cross-link to form cell wall

35
Q

Penicillin-binding proteins (PBPs)

A
  • Transpeptidases involved in cell wall synthesis are target site for B-lactam antibiotics
  • Resistance can develop w/ PBP mutation (S. aureus)
36
Q

Structure of B-lactams

A
  1. B-lactam ring = Responsible for antibiotic effect

2. Nitrogen - Attached to b-carbon relative to the Carbonyl ring

37
Q

MOA of B-Lactams

A

Inhibit last step in Peptidoglycan synthesis by binding to PBPs –> Activates autolytic enzymes –> Cell death

  • Bactericidal
38
Q

B- Lactamases

A

Bacterial enzymes that hydrolyze & break B-lactam ring

  • Penicillinase
  • Cephalosporinase
39
Q

B-Lactamase Inhibitors MOA

A

Protects penicillin from inactivation

  • Contain B-lactam ring that has higher affinity for B-lactamase
  • No antibiotic activity
  • Used in fixed combination
40
Q

B-lactamase Inhibitors (names)

A
  • Clavulanic acid
  • Sulbactam
  • Tazobactam
  • Avibactam
41
Q

B-lactamase Inhibitors (names)

A
  • Clavulanic acid
  • Sulbactam
  • Tazobactam
  • Avibactam
42
Q

Synergistic Combinations

A

Cell wall synthesis inhibitors + Protein Synthesis inhibitors
- CWSI breaks the cell wall to allow easy entry of PSI into cell

  • Should NEVER be placed in same infusion fluid bc it will form inactive compound
43
Q

Penicillin

A
44
Q

Penicillin Spectrum

A

Gram +ve bacteria & Gram -ve (porin permit easy transmembrane entry)

Ability to reach PBPs is determined by size, charge & hydrophobicity

45
Q

Penicillin Resistance Mechanism

A
  1. Inactivation by B-lactamase
  2. Modification of target PBPs (MRSA)
  3. Impaired penetration of drug to target PBOs
  4. Inc efflux
46
Q

Types of Penicillin

A
  1. Natural
    - Penicillin G/ Benzylpenicillin
    - Penicillin V
  2. Repository
    - Penicillin G Procaine
    - Penicillin G Benzathine
47
Q

Spectrum of Natural Penicillin/ Penicillin G

A
  • Gram +ve cocci
  • Gram +ve rods
  • Gram -ve cocci
  • Most anaerobes
48
Q

Penicillin G Resistance

A

Susceptible to inactivation by B-lactamase

49
Q

Clinical Applications of Penicillin G

A
Gram +ve organism
DOC for:
1. Syphilis (Benzathine penicillin G)
2. Strep infections
3. Susceptible pneumococci
50
Q

Repository Penicillin (names)

A
  • Penicillin G Procaine

- Penicillin G Benzathine

51
Q

Pharmacokinetics of Repository Penicillin

A
52
Q

Clinical application Of Penicillin G Benzathine

A

DOC for:

  1. Syphilis
  2. Rheumatic fever prophylaxis
53
Q

Spectrum of Penicillin V

A

Similar to Penicillin G but LESS active against Gram -ve bacteria

  • More acid stable than G so can be give orally
54
Q

Clinical Application of Penicillin V

A

DOC for:
- Strep throat
(Mostly for mild-moderate infections - Pharyngitis, tonsilitis & skin infections)

55
Q

Anti-staphylococcal Penicillin (Names) &

A
  • Nafcillin
  • Oxacillin
  • Dicloxacillin
56
Q

Clinical Applications of Anti-staphylococcal Penicillin

A

B-lactamase-producing Staphylococci

  • Inactive against MRSA
  • B-lactamase resistant
57
Q

Extended- Spectrum Penicillins (Names)

A
  1. Ampicillin
  2. Amoxicillin (highest oral bioavailability for penicillin)
    - Mostly used in children & pregnancy
58
Q

Clinical applications of Amoxicillin

A
  1. Acute otitis media, Streptococcal pharyngitis, Pneumonia, Skin infections, UTIs, etc.
  2. URTI
  3. Prophylaxis for susceptible infections
  4. Prophylactic treatment for cats, dogs & human bite (Amoxicillin + Clavulanic acid)
59
Q

Clinical applications of Ampicillin

A
  • Acute otitis media, Strep pharyngitis, Pneumonia, Skin infections, UTIs, etc.
  • Treatment of dogs, cats & huma bite (Ampicillin + Sulbactam)
60
Q

Anti-pseudomonal Penicillins (names)

A
  1. Ticarcillin

2. Piperacillin

61
Q

Spectrum of Anti-pseudomonal penicillins

A

Gram -ve & Gram +ve Bacilli

- Active against P. aeruginosa

62
Q

Clinical application of Anti-pseudomonal Penicilin

A
  1. Treat P. aeruginosa
  2. Treat mod-severe infections of susceptible organisms (Uncomplicated & complicated skin, gynecologic & intra-abdominal infection, Febrile neutropenia)
63
Q

Pharmacokinetics of Penicillins

A
64
Q

AEs of Penicillins

A
  1. Hypersensitivity

2.